ArticleAsian Pacific journal of cancer prevention : APJCP2026
Adherence to Helicobacter pylori Management Consensus in Clinical Practice at Two Tertiary Hospitals: A Large Cohort Study.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany countries have launched Helicobacter pylori (HP) management guidelines to assist physicians, based on regional data. However, adherence is often assessed using questionnaires, which may not accurately reflect real-world practice. This study aimed to assess adherence to the Thailand Consensus on HP management through a retrospective chart review conducted at two tertiary hospitals in Thailand. MATERIALS AND
methodsThis retrospective study was conducted at King Chulalongkorn Memorial Hospital (KCMH), located in the capital, and Phrapokklao Hospital (PPK), located in a province. Medical records of patients diagnosed with Helicobacter pylori (HP) infection via esophagogastroduodenoscopy (EGD) with a rapid urease test (RUT) between 2019 and 2021 were reviewed. Collected data included demographics, indications for HP testing, pre-EGD preparation, treatment regimens, and follow-up practices.
results2,136 medical records were reviewed: 1,987 KCMH and 149 PPK. Most patients were Thai under universal health coverage. Pre-diagnostic preparation at KCMH showed 98.5% discontinued proton pump inhibitors (PPIs) ≥2 weeks, compared to 83.9% at PPK (p < 0.001). Antibiotic discontinuation ≥4 weeks was higher at KCMH (98.6% vs 95.3%, p = 0.009). For first-line, KCMH (74.6%) received PPI-based triple therapy for 14 days, while 77.5% at PPK received concomitant therapy. 78% at KCMH confirmed HP eradicate vs 44.1% at PPK (p < 0.001). Eradication rates were comparable (95.9% at PPK vs 89.4% at KCMH: p = 0.139).
conclusionThis study highlights suboptimal adherence to the Helicobacter pylori (HP) consensus in provincial hospitals in Thailand, suggesting that future guidelines should address healthcare limitations outside the capital to enhance the overall quality of national healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.